Profund Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Buy |
38,448
+4,413
| +13% | +$146K | 0.05% | 249 |
|
|
2025
Q1 | $1.37M | Sell |
34,035
-1,678
| -5% | -$67.4K | 0.06% | 238 |
|
|
2024
Q4 | $1.68M | Sell |
35,713
-10,339
| -22% | -$486K | 0.06% | 207 |
|
|
2024
Q3 | $2.43M | Sell |
46,052
-5,869
| -11% | -$310K | 0.09% | 164 |
|
|
2024
Q2 | $2.81M | Buy |
51,921
+25,400
| +96% | +$1.38M | 0.1% | 140 |
|
|
2024
Q1 | $1.86M | Sell |
26,521
-21,228
| -44% | -$1.49M | 0.07% | 184 |
|
|
2023
Q4 | $3.99M | Buy |
47,749
+1,870
| +4% | +$156K | 0.17% | 102 |
|
|
2023
Q3 | $1.35M | Buy |
45,879
+447
| +1% | +$13.2K | 0.07% | 219 |
|
|
2023
Q2 | $1.48M | Buy |
45,432
+5,358
| +13% | +$175K | 0.08% | 211 |
|
|
2023
Q1 | $1.41M | Buy |
40,074
+34,405
| +607% | +$1.21M | 0.09% | 199 |
|
|
2022
Q4 | $260K | Sell |
5,669
-574
| -9% | -$26.3K | 0.02% | 739 |
|
|
2022
Q3 | $302K | Buy |
6,243
+477
| +8% | +$23.1K | 0.02% | 589 |
|
|
2022
Q2 | $227K | Sell |
5,766
-1,089
| -16% | -$42.9K | 0.01% | 828 |
|
|
2022
Q1 | $252K | Sell |
6,855
-716
| -9% | -$26.3K | 0.01% | 1088 |
|
|
2021
Q4 | $345K | Sell |
7,571
-387
| -5% | -$17.6K | 0.01% | 878 |
|
|
2021
Q3 | $284K | Buy |
+7,958
| New | +$284K | 0.01% | 1001 |
|
|
2018
Q4 | – | Sell |
-10,029
| Closed | -$99K | – | 1219 |
|
|
2018
Q3 | $99K | Sell |
10,029
-966
| -9% | -$9.54K | ﹤0.01% | 1515 |
|
|
2018
Q2 | $91K | Buy |
+10,995
| New | +$91K | ﹤0.01% | 1469 |
|